Yaron Naos
2019
In 2019, Yaron Naos earned a total compensation of $385.7K as Senior Vice President, Operations at Protalix BioTherapeutics, a 14% increase compared to previous year.
Compensation breakdown
| Option Awards | $79,868 |
|---|---|
| Salary | $223,318 |
| Other | $82,553 |
| Total | $385,739 |
Naos received $223.3K in salary, accounting for 58% of the total pay in 2019.
Naos also received $79.9K in option awards and $82.6K in other compensation.
Rankings
In 2019, Yaron Naos' compensation ranked 12,442nd out of 13,971 executives tracked by ExecPay. In other words, Naos earned more than 10.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,442 out of 13,971 | 11th |
Division Manufacturing | 5,029 out of 5,701 | 12th |
Major group Chemicals And Allied Products | 1,981 out of 2,200 | 10th |
Industry group Drugs | 1,704 out of 1,886 | 10th |
Industry Biological Products, Except Diagnostic Substances | 368 out of 389 | 5th |
Source: SEC filing on April 15, 2020.
Naos' colleagues
We found six more compensation records of executives who worked with Yaron Naos at Protalix BioTherapeutics in 2019.
2019
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2019
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2019
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2019
Dror Bashan
Protalix BioTherapeutics
Chief Executive Officer
2019
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2019
Eyal Rubin
Protalix BioTherapeutics
Chief Financial Officer
News
Protalix BioTherapeutics CEO Dror Bashan's 2023 pay jumps 83% to $2.7M
April 29, 2024
Protalix BioTherapeutics CEO Dror Bashan's 2022 pay jumps 27% to $1.5M
May 18, 2023
Protalix BioTherapeutics CEO Dror Bashan's 2021 pay slips 14% to $1.2M
April 29, 2022
Protalix BioTherapeutics CEO Moshe Manor's 2019 pay slips 14% to $616K
April 15, 2020
Protalix BioTherapeutics CEO Moshe Manor's 2018 pay falls 23% to $718K
April 12, 2019